Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study
暂无分享,去创建一个
G. Scambia | G. Ferrandina | V. Masciullo | F. Mascilini | G. Corrado | A. Di Legge | A. Savarese | M. Distefano | P. Malaguti | R. Samaritani